Texas Tech University Health Sciences Center El Paso is a public university focused on the health sciences and located in El Paso, Texas. It was founded in 1969 as a branch campus of the Texas Tech University Health Sciences Center and became a separate institution in 2013.

During the past decade, Texas Tech University Health Sciences Center conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 33 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 24 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Tech University Health Sciences Center" #1 sponsor was "Texas Tech University Health Sciences Center, El Paso" with 25 trials, followed by "Johns Hopkins Bloomberg School of Public Health" with 6 trials sponsored, "National Cancer Institute (NCI)" with 4 trials sponsored, "HemoSonics LLC" with 3 trials sponsored and "Phathom Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Tech University Health Sciences Center" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Johns Hopkins University" with 3 trials as a collaborator, "Massachusetts General Hospital" with 3 trials as a collaborator and "Temple University" with 3 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Texas Tech University Health Sciences Center" are "Gastroparesis" (10 trials), "Diabetic Gastroparesis" (9 trials), "Idiopathic Gastroparesis" (5 trials), "HIV Infections" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Texas Tech University Health Sciences Center" in a lesser frequency.

Most popular intervention types in "Texas Tech University Health Sciences Center" are "Drug" (61 trials), "Other" (18 trials), "Device" (14 trials), "Diagnostic Test" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Laboratory Biomarker Analysis" (3 trials), "Quality-of-Life Assessment" (3 trials), "Quantra System" (3 trials) and "Vonoprazan" (3 trials). Other intervention names were less common.

The vast majority of trials in "Texas Tech University Health Sciences Center" are 97 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 33 active trials in "Texas Tech University Health Sciences Center". 1 are not yet recruiting, 18 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 58 completed trials in Texas Tech University Health Sciences Center, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Tech University Health Sciences Center, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 22 trials that are defined as “Not Applicable".